Global Ureteroscope Market Size, Share, Opportunities, And Trends By Type (Flexible Ureteroscope, Rigid Ureteroscope, Semi-Rigid Ureteroscope), By Application (Urolithiasis, Kidney Cancer, Urinary Stricture, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers), And Geography - Forecasts From 2025 To 2030

Ureteroscope Market Size:

The Global Ureteroscope Market is expected to grow from US$721.856 million in 2025 to US$943.842 million in 2030, at a CAGR of 5.51%.

A ureteroscope is a small instrument inserted into the bladder and ureter to diagnose and treat a variety of problems in the urinary tract. The purview of ureteroscopy has broadened from diagnostic endoscopy to various minimally invasive procedures. Growth in the ureteroscope market is significantly driven by the rising incidence of urolithiasis, coupled with the increasing prevalence of urologic cancers. Also, the growing adoption and demand for minimally invasive procedures are anticipated to play a crucial role in augmenting the market growth during the forecast period. Moreover, the rise in research and development activities in ureteroscopes is expected to boost the growth of the global ureteroscope market. However, the high cost of ureteroscope is expected to hinder the market growth. Furthermore, the rising prevalence of obesity, diabetes, and a growing geriatric population are expected to surge the incidences of diseases of the urinary tract, which in turn is anticipated to propel the global ureteroscope market growth during the assessment period.

The recent outbreak of the novel coronavirus disease had a negative impact on the global ureteroscope market. The pandemic shifted the major focus of the healthcare system towards COVID-19, and as part of the COVID-19 restrictions, a large number of surgeries had to be cancelled in many parts of the world, which led to a decline in the global ureteroscope market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

Ureteroscope Market Growth Drivers:

• Rising prevalence of urolithiasis.

One of the major factors anticipated to drive the growth of the global ureteroscope market during the forecast period is the growing number of cases of urolithiasis, which is expected to surge the demand for ureteroscopes. According to an article published in the Journal of Family Medicine and Primary Care in December 2020, the prevalence of urolithiasis has been increasing around the world with a prevalence of 7–13% in North America, 5-9% in Europe 5–9%, and 1-5% in Asia. It also states that the United States will have an expected additional expenditure of $1.24 billion/year by 2030 due to a rise in the number of cases of urolithiasis. An article published by Advanced Biomedical Research in the US National Library of Medicine, National Institutes of Health, showed that diabetes increases the risk of urolithiasis. As perthe  International Diabetes Federation, 9.3% of the global population, i.e., 463 million people, had diabetes in 2019, which is projected to increase to 10.2%, i.e., 578 million, by 2030 and 10.9% i.e., 700 million by 2045. This is leading to an increased prevalence of urolithiasis, which is anticipated to propel the growth of the global ureteroscope market during the assessment period.

• Growing demand for minimally invasive surgeries.

The rise in the adoption and demand for minimally invasive surgeries, due to their various advantages over traditional surgeries, is prompting increased use of ureteroscopes, which is anticipated to propel the growth of the global ureteroscope market during the forecast period. The minimally invasive surgery requires smaller incisions and consequently less scar tissue, which are some of the reasons for its rising preference. Minimally invasive surgeries reduce the hospital stay time for the patient and have shorter recovery periods, along with providing increased accuracy, which is prompting the demand for minimally invasive surgeries. Another article published in February 2020 in the US NLM, NIH, showed that open surgical procedures declined by nearly 35% from 2000 to 2018 and are being replaced by minimally invasive surgeries. This rising demand is expected to grow further in the coming years and is anticipated to boost the global ureteroscope market growth during the forecast period.

Ureteroscope Market Geographical Outlook:

• North America is to hold a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to a large presence of conditions that lead to urolithiasis and other complications requiring the use of a ureteroscope. The United States has a high prevalence of diabetes, which increases the risk of urolithiasis, which is one of the reasons for the high market share of North America. Also, the presence of an advanced healthcare system contributed to the domination of North America in the global ureteroscope market. The Asia Pacific region is anticipated to witness substantial growth due to rising cases of urolithiasis in the region and the increasing number of people with obesity. Also, the increased expenditure in the healthcare industry is further anticipated to propel the market growth in the Asia Pacific during the forecast period.

Ureteroscope Market Scope:

Report Metric	Details
Ureteroscope Market Size in 2025	US$721.856 million
Ureteroscope Market Size in 2030	US$943.842 million
Growth Rate	CAGR of 5.51%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Million
Segmentation	Type Application End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Ureteroscope Market	Boston Scientific Corporation Olympus Corporation Richard Wolf GmbH PENTAX Medical Clarion Medical Technologies
Customization Scope	Free report customization with purchase

 

The Ureteroscope Market is analyzed into the following segments:

• By Type
  • Flexible Ureteroscope
  • Rigid Ureteroscope
  • Semi-Rigid Ureteroscope
• By Application
  • Urolithiasis
  • Kidney Cancer
  • Urinary Stricture
  • Others
• By End-User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • UK
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

---

1. Introduction

1.1. Market Definition

1.2. Market Segmentation

2. Research Methodology

2.1. Research Data

2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of End-Users

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. Global Ureteroscope Market Analysis, by Type

5.1. Introduction

5.2. Flexible Ureteroscope

5.3. Rigid Ureteroscope

5.4. Semi-Rigid Ureteroscope

6. Global Ureteroscope Market Analysis, by Application

6.1. Introduction

6.2. Urolithiasis

6.3. Kidney Cancer

6.4. Urinary Stricture

6.5. Others

7. Global Ureteroscope Market Analysis, by Technology Type

7.1. Introduction

7.2. Digital Ureteroscope

7.3. Fiber-Optic Ureteroscope

8. Global Ureteroscope Market Analysis, by End-User

8.1. Introduction

8.2. Hospitals and Clinics

8.3. Ambulatory Surgical Centers

8.4. Diagnostic Centers

9. Global Ureteroscope Market Analysis, by Geography

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. UK

9.4.4. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Taiwan

9.6.6. Thailand

9.6.7. Indonesia

9.6.8. Others

10. Competitive Environment and Analysis

10.1. Major Players and Strategy Analysis

10.2. Emerging Players and Market Lucrativeness

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

11. Company Profiles

11.1. Boston Scientific Corporation

11.2. Olympus Corporation

11.3. Richard Wolf GmbH

11.4. Clarion Medical Technologies Inc.

11.5. Stryker Corporation

11.6. Karl Storz SE & Co. KG

11.7. ELMED Medical Systems

11.8. Dornier MedTech GmbH

11.9. B. Braun Melsungen AG

11.10. Maxer Endoscopy GmbH

11.11. UroViu Corporation

Boston Scientific Corporation

Olympus Corporation

Richard Wolf GmbH

Clarion Medical Technologies Inc.

Stryker Corproation 

Karl STorz SE & Co. KG

ELMED Medical Systems

Dornier MedTech GmbH

B.Braun Melsungen AG 

Maxer Endoscopy GmbH

UroViu Corporation